( NASDAQ-NMS:LMNX )

News from Luminex Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

05 Jun, 2017, 08:00 ET Luminex Corporation's VERIGENE Gram-Positive and Gram-Negative Blood Culture Panels Receive Reimbursement Approval in Japan

Luminex Corporation (NASDAQ: LMNX) today announced that Japan's Central Social Insurance Medical Council has approved the recommendation by the...


25 May, 2017, 08:30 ET Luminex Corporation To Present At Jefferies 2017 Global Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Jefferies 2017 Global Healthcare Conference on Thursday,...


24 May, 2017, 08:30 ET Luminex Corporation Declares Second Quarter Cash Dividend

Luminex Corporation (NASDAQ:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the second quarter of...


03 May, 2017, 08:00 ET Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay

Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Bordetella Assay for direct detection and...


01 May, 2017, 16:05 ET Luminex Corporation Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance

Luminex Corporation (NASDAQ:LMNX) today announced financial results for the first quarter of 2017. Financial and operating highlights for the...


26 Apr, 2017, 08:30 ET Luminex Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference

Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Deutsche Bank 42nd Annual Health Care Conference on...


20 Apr, 2017, 08:30 ET Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference

Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Bank of America Merrill Lynch 2017 Health Care Conference on...


10 Apr, 2017, 16:05 ET Luminex Corporation First Quarter Earnings Release Scheduled for May 1, 2017

Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the first quarter ended March 31, 2017 on Monday, May 1,...


21 Feb, 2017, 16:05 ET Luminex Corporation Announces Initiation of Cash Dividend

Luminex Corporation (NASDAQ: LMNX) (the "Company") today announced that its board of directors has authorized the initiation of a quarterly cash...


06 Feb, 2017, 16:05 ET Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full year 2016 ended December 31, 2016. Financial...


09 Jan, 2017, 08:30 ET Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance; To Present at 35th Annual J.P. Morgan Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) today announced that it expects revenues in the fourth quarter of 2016 to be approximately $72 million and...


04 Jan, 2017, 08:00 ET Luminex Corporation Receives FDA Clearance for ARIES® GBS Assay

Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Group B Streptococcus (GBS) Assay for...


05 Dec, 2016, 08:00 ET Luminex wins R&D 100 Award for ARIES Systems

Luminex Corporation (NASDAQ: LMNX) today announced that the company was awarded the prestigious R&D 100 Award for its ARIES® Systems at the...


17 Nov, 2016, 14:30 ET ARIES System und Flu A/B & RSV Assay von Erasmus MC in neuer Publikation evaluiert

Publikation im Journal of Clinical Virology demonstriert Effektivität und einfache Handhabung für Routinetests  Die Luminex Corporation...


17 Nov, 2016, 12:39 ET Le centre médical Érasme évalue le système ARIES et le kit de dépistage de la grippe A/B et du RSV dans une nouvelle publication

Le Journal of Clinical Virology démontre l'efficacité et la facilité d'utilisation pour les tests de routine Luminex Corporation (NASDAQ :...


17 Nov, 2016, 08:00 ET ARIES System and Flu A/B & RSV Assay Evaluated by Erasmus MC in New Publication

Luminex Corporation (NASDAQ: LMNX) today announced that the internationally renowned Department of Viroscience at Erasmus Medical Center in...


07 Nov, 2016, 16:05 ET Luminex Corporation To Present At The 28th Annual Piper Jaffray Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 28th Annual Piper Jaffray Healthcare Conference to be...


31 Oct, 2016, 16:05 ET Luminex Corporation Reports Third Quarter 2016 Results; Raises Full Year Guidance

Luminex Corporation (NASDAQ:LMNX) today announced financial results for the third quarter ended September 30, 2016. Financial and operating...


11 Oct, 2016, 16:05 ET Luminex Corporation Third Quarter Earnings Release Scheduled for October 31, 2016

Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the third quarter ended September 30, 2016 on Monday,...


08 Aug, 2016, 08:30 ET Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay

 Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...


03 Aug, 2016, 08:30 ET Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus

 Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Flu A/B & RSV Assay. This...


28 Jul, 2016, 16:05 ET Luminex Corporation Reports Second Quarter 2016 Results

 Luminex Corporation (NASDAQ:LMNX) today announced financial results for the second quarter ended June 30, 2016.  Financial and operating...


20 Jul, 2016, 08:30 ET Luminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time

Luminex Corporation (NASDAQ: LMNX) today announced that it will now hold a conference call to discuss the second quarter operating highlights and...


08 Jul, 2016, 08:30 ET Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016

 Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter ended June 30, 2016 on Thursday,...


06 Jul, 2016, 14:38 ET Luminex Corporation obtient l'autorisation de la FDA et le marquage CE-DIV pour son système ARIES M1

L'extension de la plateforme ARIES offre des avantages significatifs aux laboratoires cliniques présentant des exigences de débit inférieures...